MedTrace Logo

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates

NCT06689488 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-06-26

No results posted yet for this study

Summary

The overall purpose of this study is to characterise the clinical safety and performance of the Creo Medical MicroBlate™ Flex AB1 instrument in patients with pathologically confirmed malignancy eligible for surgical resection of their nodule, receiving bronchoscopic ablation prior to surgery.

Conditions

Interventions

DEVICE

Ablation

Bronchoscopy and microwave ablation prior to surgical resection.

Sponsors & Collaborators

  • Creo Medical Limited

    lead INDUSTRY

Principal Investigators

  • Jouke T Annema, MD · Amsterdam University Medical Centres

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-17
Primary Completion
2026-04-30
Completion
2026-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06689488 on ClinicalTrials.gov